ARE vs LAB · P/E 100, $13.19B cap vs rev $174.4M
Alexandria Real Estate Equities Inc (ARE) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Alexandria Real Estate Equities Inc (ARE) is a reit - office company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
ARE does not have a complete income-statement cache yet.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
ARE currently screens at market cap $13.19B and trailing P/E 100.4. LAB currently screens at market cap $317.1M.
Not investment advice. Open the ARE and LAB stock pages for the full models.
Not investment advice.